Lymphoma | Topics

IFRT Appears Safe, Effective Standard of Care for Some Pediatric Patients with High-Risk cHL
November 25, 2020

A study presented at ASTRO suggested that response-based consolidation involved-field radiation therapy appears to be a safe and effective standard of care for a cohort of pediatric patients with high-risk classical Hodgkin lymphoma.

FDA Will Not Complete Review of BLA for Lisocabtagene Maraleucel By PDUFA Date
November 17, 2020

The priority review of the biologics license application for lisocabtagene maraleucel (liso-cel) for the treatment of adults with relapsed or refractory large B-cell lymphoma after at least 2 prior therapies will not be completed by the prescription drug user fee act date.

SGX301 Demonstrates Positive Benefits for Cutaneous T-Cell Lymphoma
October 22, 2020

Cycle 3 of the FLASH study reported that patients taking SGX301 to treat cutaneous t-cell lymphoma saw improved responses and maintained a positive safety profile.